Familial Association of Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

about

Familial Association of Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q47350920

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Familial Association of Granul ...... in Inflammatory Bowel Disease.

@en

Familial Association of Granul ...... in Inflammatory Bowel Disease.

@nl

type

Item

label

Familial Association of Granul ...... in Inflammatory Bowel Disease.

@en

Familial Association of Granul ...... in Inflammatory Bowel Disease.

@nl

prefLabel

Familial Association of Granul ...... in Inflammatory Bowel Disease.

@en

Familial Association of Granul ...... in Inflammatory Bowel Disease.

@nl

P1476

Familial Association of Granul ...... in Inflammatory Bowel Disease

@en

P2093

Anna Trauernicht

http://www.w3.org/2001/XMLSchema#string

Bruce C Trapnell

http://www.w3.org/2001/XMLSchema#string

Claudia Chalk

http://www.w3.org/2001/XMLSchema#string

Courtney A McCall

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Maier

http://www.w3.org/2001/XMLSchema#string

Erin Bonkowski

http://www.w3.org/2001/XMLSchema#string

Kathleen Lake

http://www.w3.org/2001/XMLSchema#string

Lee A Denson

http://www.w3.org/2001/XMLSchema#string

Ramona Bezold

http://www.w3.org/2001/XMLSchema#string

Sandra S Wright

http://www.w3.org/2001/XMLSchema#string

P2860

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease

Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications

Sargramostim for active Crohn's disease

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

Adult-onset immunodeficiency in Thailand and Taiwan.

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.

Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.

P304

767-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPG.0000000000001851

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mi-Ok Kim

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29216019

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

5916026

http://www.w3.org/2001/XMLSchema#string